Fiechtner Research, Inc.

Lansing, Michigan 48910

0 studies enrolling now · 9 studies all time

What they study most

Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab — Stopped early
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) — Stopped early
• A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX — Completed
• A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis — Completed
• Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) — Completed
• A Study of Belimumab in Subjects With Systemic Lupus Erythematosus — Completed
• Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis — Completed
• Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE) — Stopped early
• Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis — Completed